API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Chlorpheniramine Maleate SR Pellets are extended-release multiarticulate formulations designed for sustained delivery of the antihistamine Chlorpheniramine Maleate. These pellets are commonly used in the pharmaceutical industry for manufacturing sustained-release capsules or tablets, ensuring controlled release for prolonged therapeutic effect.
| Component | Function |
|---|---|
| Chlorpheniramine Maleate | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Spheres | Inert core or starter pellets |
| Hydroxypropyl Methylcellulose (HPMC) | Binder / Film former during layering |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Eudragit RS / RL | Sustained release polymer coating |
| Triethyl Citrate / PEG 6000 | Plasticizer (for sustained release coating) |
| Purified Water | Solvent (removed after processing) |
Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Chlorpheniramine Maleate or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
SR (Sustained Release) pellets provide a controlled and prolonged release of the drug, reducing dosing frequency and improving patient compliance.
Yes, they can be combined with other pellets in the same capsule or formulation, provided there is no incompatibility between APIs and excipients.
Yes, we provide COA, MSDS, stability data, and DMF (Drug Master File) support upon request.
We supply complete regulatory documentation, stability reports, and technical data to support registration and clearance in various markets.